Pancreatic Cancer Research

ResearcherUniversity Hospital MünsterNo recent work listed

Jörg Haier

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1278-9438; OpenAlex author ID A5083490249. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2011: 2 papers · 2012: none · 2013: 1 paper · 2014: none · 2015: 3 papers · 2016: 1 paper

Papers 7

  1. SERPINB5 Promoter Hypomethylation Differentiates Pancreatic Ductal Adenocarcinoma From Pancreatitis. Co-author DOI 10.1097/mpa.0000000000000526↗
  2. MiR-23a/-24-induced gene silencing results in mesothelial cell integration of pancreatic cancer. Last author DOI 10.1038/bjc.2014.587↗
  3. MicroRNA-100 and microRNA-21 as markers of survival and chemotherapy response in pancreatic ductal adenocarcinoma UICC stage II. Co-author DOI 10.1186/s13148-015-0166-1↗
  4. MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1371/journal.pone.0143755↗
  5. Epigenetic regulation and role of metastasis suppressor genes in pancreatic ductal adenocarcinoma. First author DOI 10.1186/1471-2407-13-264↗
  6. Epigenetic markers for chemosensitivity and chemoresistance in pancreatic cancer--a review. Last author DOI 10.1002/ijc.26078↗
  7. Role of tumor microenvironment on gene expression in pancreatic cancer tumor models. Last author DOI 10.1016/j.jss.2010.03.034↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wolf Arif Mardin · 7 shared papers, 2011–2016 · strength 0.37
  2. Soeren Torge Mees · 6 shared papers, 2011–2016 · strength 0.31
  3. Sameer Abdallah Dhayat · 4 shared papers, 2011–2016 · strength 0.21
  4. Norbert J. Senninger · 4 shared papers, 2011–2016 · strength 0.21
  5. H Listing · 1 shared paper, 2015 · strength 0.06
  6. Anda Ströse · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.